CCSI和Spacelabs公司共同推出NICU新设备

 
一种新型制图和文档模块，被设计用于新生儿重症监护室（NICU），帮助医生监护患重病的婴儿。

该模块能够进行持续的文件记录，从患者稳定性到出院、高风险、低风险手术清单，提示手术的耐受程度和介入、环境检查和报警界限以及系统评估，来自其他NICU设备的登录，对呼吸暂停和心动过缓发作进行记录。

这种制图模块叫做OBiX围产期资料系统，是由临床计算机系统公司（CCSI）研制成功的，由CCSI和Spacelabs共同推向市场。该模块能够在现在的Spacelabs患者监视系统上进行观察，允许护理人员在放置在床边的设备上使用。Spacelabs公司为这种NICU提供了专门设计的各种监视器。

Spacelabs监视器配备WinDNA后，方便了临床医生直接在床边监视器上观察和控制Windows应用程序，允许在患者屏幕上展示各种实验室和诊断检查结果以及文档。

Spacelabs公司的总裁兼首席执行官Dave Tilly说：“这种模块证明通过合作，我们能够提供最佳解决方案。我们的目标是帮助临床工作人员作出更加有效率、知情更好的决策，使他们能够花更多时间来护理最小的、最容易收到伤害的患者。”

Charting Module for NICU
 
A new charting and documentation module is designed for use in the neonatal intensive care unit (NICU) to aid doctors in caring for critically ill babies.

The module provides a continuum of documentation from stabilization through discharge, high- and low-risk procedure listings indicating procedure tolerance and interventions, and environmental check and alarms limits, as well as systemic assessments, entries from other NICU devices, and ongoing episodic records of apneic and bradycardic occurrences.

The charting module, called the OBiX perinatal data system, was developed by Clinical Computer Systems, Inc. (CCSI, Elgin, IL, USA) and is jointly marketed by CCSI and Spacelabs Medical, Inc. (Issaquah, WA, USA). The module can be viewed on an existing Spacelabs patient monitoring system, enabling nursing staff to use it right at bedside on equipment already in place. Spacelabs offers a variety of monitors designed for the NICU.

Spacelabs monitors equipped with WinDNA enable clinicians to view and control Windows applications directly on the patient’s bedside monitor, permitting the display of extensive laboratory and diagnostic test results and documentation on one patient screen.

“The module demonstrates the kind of ‘best of breed’ solutions we can provide by working together,” said Dave Tilly, president and CEO of Spacelabs. “Our goal is to help clinical staff make more efficient, better-informed decisions, giving them the gift of more time to care for their smallest, most vulnerable patients.”